Naringenin enhances the efficacy of ferroptosis inducers by attenuating aerobic glycolysis by activating the AMPK-PGC1α signalling axis in liver cancer

Liver cancer is a heterogeneous disease characterized by poor responses to standard therapies and therefore unfavourable clinical outcomes. Understanding the characteristics of liver cancer and developing novel therapeutic strategies are imperative. Ferroptosis, a type of programmed cell death induc...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Yong-Zhuo Li, Jing Deng, Xiao-Dong Zhang, Dong-Yang Li, Li-Xi Su, Shan Li, Jian-Min Pan, Lan Lu, Jia-Qi Ya, Nuo Yang, Jing Zhou, Li-Hui Yang
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Elsevier 2024-06-01
Sarja:	Heliyon
Aiheet:	Naringenin Ferroptosis Aerobic glycolysis AMPK-PGC1α signalling axis Liver cancer
Linkit:	http://www.sciencedirect.com/science/article/pii/S2405844024083191
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!